William Blair & Company
NXTM

William Blair & Company’s NxStage Medical Inc. NXTM Stock Holding History

William Blair & Company’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-115,705
Closed -$3.31M – 1760
2018
Q4 		$3.31M Buy
115,705
+445
+0.4% +$12.6K 0.02% 415
2018
Q3 		$3.21M Buy
115,260
+3,315
+3% +$93.2K 0.02% 460
2018
Q2 		$3.12M Sell
111,945
-664
-0.6% -$17.8K 0.02% 463
2018
Q1 		$2.8M Buy
112,609
+865
+0.8% +$21K 0.02% 482
2017
Q4 		$2.71M Sell
111,744
-81,189
-42% -$2.14M 0.02% 499
2017
Q3 		$5.33M Sell
192,933
-405,738
-68% -$10.8M 0.04% 322
2017
Q2 		$15M Sell
598,671
-173,663
-22% -$4.3M 0.11% 193
2017
Q1 		$21.3M Sell
772,334
-59,142
-7% -$1.63M 0.17% 144
2016
Q4 		$21.8M Sell
831,476
-26,385
-3% -$653K 0.19% 127
2016
Q3 		$21.4M Sell
857,861
-328,381
-28% -$7.66M 0.19% 136
2016
Q2 		$19.6M Buy
1,186,242
+258,162
+28% +$4.61M 0.18% 142
2016
Q1 		$13.9M Buy
928,080
+80,205
+9% +$1.34M 0.13% 172
2015
Q4 		$18.6M Buy
847,875
+14,777
+2% +$275K 0.17% 139
2015
Q3 		$13.1M Sell
833,098
-632,116
-43% -$10.1M 0.11% 194
2015
Q2 		$20.9M Sell
1,465,214
-100,544
-6% -$1.7M 0.03% 628
2015
Q1 		$27.1M Sell
1,565,758
-1,084,306
-41% -$19.2M 0.04% 482
2014
Q4 		$47.5M Sell
2,650,064
-982,137
-27% -$15.8M 0.08% 345
2014
Q3 		$47.7M Sell
3,632,201
-52,862
-1% -$712K 0.08% 321
2014
Q2 		$53M Sell
3,685,063
-355,025
-9% -$4.64M 0.09% 312
2014
Q1 		$51.5M Buy
4,040,088
+205,658
+5% +$2.68M 0.09% 322
2013
Q4 		$38.3M Buy
3,834,430
+417,150
+12% +$4.73M 0.06% 390
2013
Q3 		$45M Sell
3,417,280
-159,964
-4% -$2.1M 0.08% 353
2013
Q2 		$51.1M Buy
+3,577,244
New +$45M 0.1% 308

Other funds holding NXTM

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

William Blair & Company's NXTM Position: Q1 2019 in Review

William Blair & Company sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 115,705 shares — an estimated $3.31M sold.

William Blair & Company first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $53M in Q2 2014. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • William Blair & Company reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • William Blair & Company sold 115,705 NxStage Medical Inc. shares in Q1 2019, an estimated $3.31M.
  • William Blair & Company first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
  • William Blair & Company's NxStage Medical Inc. position peaked at $53M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on William Blair & Company's 13F filing for Q1 2019, filed 14 May 2019.